References
- Ellenhorn M J, Barceloux D G. Halogenated 8-hydroxyquinolines, therapeutic drugs. Medical Toxicology–-Diagnosis and Treatment of Human Poisoning. Elsevier, New York 1988; 362–364
- Baumgartner G, Gawel M J, Kaeser H E, et al. Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. J Neurol Neurosurg Psychiatry 1979; 42: 1073–1083
- Savitt D L, Hawkins H H, Roberts J R. The radiopacity of ingested medications. Ann Emerg Med 1987; 16: 331–339
- Berggren L, Hansson O. Absorption of intestinal antiseptics derived from 8-hydroxyquinolines. Clin Pharm Therap 1968; 9: 67–70
- Fischer T, Hartvig P. Skin absorption of 8-hydroxyquinolines (letter). Lancet 1977; 709: 603
- Oakley G P. The neurotoxicity of the halogenated hydroxyquinolines. JAMA 1973; 225: 395–397
- Kaeser H E. Transient global amnesia due to clioquinol. Acta Neurol Scand 1984; 70(suppl 100)175–179
- Ferrier T M, Schwieger A C, Eadie M J. Delayed onset of partial epilepsy of temporal lobe origin following acute clioquinol encephalopathy. J Neurol Neurosurg Psychiatry 1987; 50: 93–95
- Schantz B, Wikstrom B. Suspected poisoning with oxyquinoline preparations in dogs. Svenska Vet Tidn 1965; 17: 106–107
- Committee on drugs. 1989–1990, American Academy of Pediatrics: Clioquinol (Iodochlorhydroxyquin, Vioform) and Iodoquinol (Diiodohydroxyquin): Blindness and Neuropathy. Pediatrics 1990; 86: 797–798